asthma & copd medications · asthma & copd medications seebri breezhaler ^ glycopyrronium...

ASTHMA & COPD MEDICATIONS Seebri Breezhaler ^ glycopyrronium 50mcg Onbrez Breezhaler ^ indacaterol 150mcg • 300mcg Spiriva Respimat ^ tiotropium 2.5mcg Spiriva Handihaler ^ tiotropium 18mcg SABA RELIEVERS Bricanyl Turbuhaler † ^ terbutaline 500mcg Airomir Autohaler ‡ ^ salbutamol 100mcg Asmol Inhaler † ^ salbutamol 100mcg Ventolin Inhaler † ^ salbutamol 100mcg Atrovent Metered Aerosol † ^ ipratropium 21mcg ICS/LABA COMBINATIONS LAMA MEDICATIONS LAMA/LABA COMBINATIONS SAMA MEDICATION Seretide MDI ‡ fluticasone propionate/salmeterol 50/25 • 125/25 • 250/25 # Seretide Accuhaler ‡ fluticasone propionate/salmeterol 100/50 • 250/50 • 500/50 # Symbicort Turbuhaler ‡ budesonide/formoterol 100/6 • 200/6 • 400/12 # QVAR Autohaler ‡ beclometasone 50mcg • 100mcg Pulmicort Turbuhaler † budesonide 100mcg • 200mcg • 400mcg Flixotide Accuhaler † fluticasone propionate 100mcg* • 250mcg • 500mcg Flixotide Inhaler † fluticasone propionate 50mcg* • 125mcg • 250mcg *Flixotide Junior Alvesco Inhaler † ciclesonide 80mcg • 160mcg ICS PREVENTERS Singulair Tablet a montelukast 4mg • 5mg • 10mg Tilade Inhaler † nedocromil sodium 2mg Intal Inhaler † sodium cromoglycate 1mg • 5mg* *Intal Forte NON STEROIDAL PREVENTERS 2016 This chart was developed independently by the National Asthma Council Australia with support from AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Mundipharma and Novartis † Asthma unrestricted benefit ‡ Asthma restricted benefit a Asthma authority required benefit ^ COPD unrestricted benefit # COPD restricted benefit c COPD authority required benefit Check TGA and PBS for current age and condition criteria RESOURCES TREATMENT GUIDELINES Australian Asthma Handbook: asthmahandbook.org.au COPD-X Plan: copdx.org.au INHALER TECHNIQUE How-to videos, patient and practitioner information nationalasthma.org.au Inhalers/MDIs should be used with a compatible spacer QVAR Inhaler † beclometasone 50mcg • 100mcg Montelukast Tablet a montelukast 4mg • 5mg Generic medicine suppliers Bretaris Genuair ^ aclidinium 322mcg Incruse Ellipta ^ umeclidinium 62.5mcg Brimica Genuair c aclidinium/formoterol 340/12 Anoro Ellipta c umeclidinium/vilanterol 62.5/25 Spiolto Respimat c tiotropium/olodaterol 2.5/2.5 Ultibro Breezhaler c indacaterol/glycopyrronium 110/50 Symbicort Rapihaler ‡ budesonide/formoterol 50/3 • 100/3 • 200/6 # Flutiform Inhaler ‡ fluticasone propionate/formoterol 50/5 • 125/5 • 250/10 Breo Ellipta ‡ fluticasone furoate/vilanterol 100/25 # • 200/25 Oxis Turbuhaler ‡ formoterol 6mcg • 12mcg Serevent Accuhaler ‡ salmeterol 50mcg LABA MEDICATIONS PBS PRESCRIBERS © National Asthma Council Australia ICS, inhaled corticosterioid | LABA, long-acting beta 2 agonist | LAMA, long-acting muscarinic antagonist | SABA, short-acting beta 2 agonist | SAMA, short-acting muscarinic antagonist

Upload: vandieu

Post on 21-Apr-2018

505 views

Category:

Documents

11 download

Report

Download

Embed Size (px):

TRANSCRIPT

ASTHMA & COPD MEDICATIONS

Seebri Breezhaler ^glycopyrronium 50mcg

Onbrez Breezhaler ^indacaterol150mcg • 300mcg

Spiriva Respimat ^ tiotropium 2.5mcg

Spiriva Handihaler ^tiotropium 18mcg

SABA RELIEVERS

Bricanyl Turbuhaler † ^terbutaline 500mcg

Airomir Autohaler ‡ ^ salbutamol 100mcg

Asmol Inhaler † ^ salbutamol 100mcg

Ventolin Inhaler † ^salbutamol 100mcg

Atrovent Metered Aerosol † ^ipratropium 21mcg

ICS/LABA COMBINATIONS LAMA MEDICATIONS

LAMA/LABA COMBINATIONS

SAMA MEDICATION

Seretide MDI ‡fluticasone propionate/salmeterol 50/25 • 125/25 • 250/25 #

Seretide Accuhaler ‡fluticasone propionate/salmeterol100/50 • 250/50 • 500/50 #

Symbicort Turbuhaler ‡budesonide/formoterol100/6 • 200/6 • 400/12 #

QVAR Autohaler ‡

beclometasone50mcg • 100mcg

Pulmicort Turbuhaler †budesonide 100mcg • 200mcg • 400mcg

Flixotide Accuhaler †fluticasone propionate100mcg* • 250mcg • 500mcg

Flixotide Inhaler † fluticasone propionate50mcg* • 125mcg • 250mcg*Flixotide Junior

Alvesco Inhaler †ciclesonide80mcg • 160mcg

ICS PREVENTERS

Singulair Tablet amontelukast4mg • 5mg • 10mg

Tilade Inhaler †nedocromil sodium 2mg

Intal Inhaler † sodium cromoglycate1mg • 5mg**Intal Forte

NON STEROIDAL PREVENTERS

2016

This chart was developed independently by the National Asthma Council Australia with support from AstraZeneca, Boehringer-Ingelheim,

GlaxoSmithKline, Mundipharma and Novartis

† Asthma unrestricted benefit‡ Asthma restricted benefita Asthma authority required benefit

^ COPD unrestricted benefit # COPD restricted benefitc COPD authority required benefit

Check TGA and PBS for current age and condition criteria

RESOURCES

TREATMENT GUIDELINESAustralian Asthma Handbook: asthmahandbook.org.au

COPD-X Plan: copdx.org.au

INHALER TECHNIQUEHow-to videos, patient and practitioner information

nationalasthma.org.au

Inhalers/MDIs should be used with a compatible spacer

QVAR Inhaler †beclometasone50mcg • 100mcg

Montelukast Tablet amontelukast4mg • 5mgGeneric medicine suppliers

Bretaris Genuair ^aclidinium 322mcg

Incruse Ellipta ^umeclidinium 62.5mcg

Brimica Genuair caclidinium/formoterol 340/12

Anoro Ellipta cumeclidinium/vilanterol62.5/25

Spiolto Respimat ctiotropium/olodaterol 2.5/2.5

Ultibro Breezhaler cindacaterol/glycopyrronium110/50

Symbicort Rapihaler ‡budesonide/formoterol50/3 • 100/3 • 200/6 #

Flutiform Inhaler ‡fluticasone propionate/formoterol50/5 • 125/5 • 250/10

Breo Ellipta ‡fluticasone furoate/vilanterol 100/25 # • 200/25

Oxis Turbuhaler ‡formoterol6mcg • 12mcg

Serevent Accuhaler ‡salmeterol 50mcg

LABA MEDICATIONS

PBS PRESCRIBERS

© National Asthma Council Australia ICS, inhaled corticosterioid | LABA, long-acting beta2 agonist | LAMA, long-acting muscarinic antagonist | SABA, short-acting beta2 agonist | SAMA, short-acting muscarinic antagonist

COPD. Objectives How important is COPD? What is COPD? How to treat COPD? What is the prognosis?

ANNEX I SUMMARY OF PRODUCT … COPD. The safety and efficacy of Ultibro Breezhaler in children have not been established. No data are available. Method of administration For inhalation

Three better than 1 or 2? - cdn.dal.ca · Past COPD medications (added therapy in response to persistent dyspnea) Ipratropium 20mcg –2 puffs qid (2008 -2012) Tiotropium once daily

PRESCRIBING DIRECTIONS FOR PSYCHOTROPIC MEDICATIONS · 1/1/2012 · worsening of depression, risk of fetal harm, withdrawal symptoms, respiratory depression, sleep apnea/COPD, worsening

[Product Monograph Template - Standard] - Novartis · PDF fileSEEBRI® BREEZHALER® Product Monograph Page 1 of 34 PRODUCT MONOGRAPH Pr SEEBRI® BREEZHALER® Glycopyrronium inhalation

Alter Obstructive Lung Disease 2.ppt - c.ymcdn.comc.ymcdn.com/sites/€¦ · Therapeutic Options: COPD Medications Beta 2-agonists Short-acting beta 2-agonists- e.g Albuterol Long-acting

Class Update: COPD Medications - orpdl. · PDF fileThe last update was in July 2014 so evidence since ... diagnosed with COPD in 2011.24 Forty‐one percent of these individuals were

EMBEDDED CONNECTED METERED DOSE INHALERS MEETING ... · Asthma attacks and COPD exacerbations are believed to be the main cost driver. Effective treatment and medications are readily

CORE AREA 2 CARDIOVASCULAR Topic C. CASE STUDY Mr. DD 60 years old smoker > 40 years Conditions: CHF and COPD Medications: - enalapril 10mg BD - frusemide

Downloaded from on March 11, …bmjopen.bmj.com/content/bmjopen/7/3/e013195.full.pdf · Open Access Research ... Case and control parti- ... of COPD medications, patients with COPD

Lecture 13 COPD Pathophysiology Dahri COPD EPIDEMIOLOGY

[Product Monograph Template - Standard] - novartis.ca breezhaler_scrip_e.pdf · Onbrez ® Breezhaler ® Product Monograph Page 5 of 34 When prescribing ONBREZ® BREEZHALER®, the